STAFF REPORTER|
THE South African Health Products Regulatory Authority (Sahpra) has made recommendations that the suspension of J&J vaccine rollout be lifted provided that specific conditions are met.
This follows the announcement last week by Health Minister Dr Zweli Mkhize that South Africa has voluntarily suspended its rollout of the J&J Covid-19 vaccine after the United States paused their rollout due to reported blood clots in recipients.
Sahpra said that it has since engaged with the Sisonke Phase 3B Implementation Study team and Janssen Pharmaceutica.
“The focus of the engagement was on the safety data reported from the Sisonke study, following administration of the Covid-19 vaccine Janssen, as well as the adverse events reported in the United States of America,” said SAHPRA in a statement.
SAHPRA has since recommended lifting the suspension on the Sisonke study, but says there should be better screening and monitoring of participants at high risk
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insidepolitic.co.za
